Vessel wall - where coagulation meets cell biology and immunology

Thrombosis and Haemostasis

Volumn 108, Issue 3, 2012, Pages 416-418

  Guzik, Tomasz J ^a   Dulak, Jozef ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE RECEPTOR CX3CR1; FIBRIN; FIBRINOGEN; FRACTALKINE; HEME OXYGENASE 1; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE;

ABDOMINAL AORTA ANEURYSM; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BLOOD VESSEL WALL; BONE MARROW CELL; CARDIOVASCULAR RISK; ENDOTHELIAL DYSFUNCTION; ERYTHROCYTE; FIBRINOGEN BLOOD LEVEL; HUMAN; IMMUNOCOMPETENT CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOSIS; VASCULITIS;

BIOLOGICAL MARKERS; BLOOD COAGULATION; C-REACTIVE PROTEIN; CEREBROVASCULAR DISORDERS; CHEMOKINE CX3CL1; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FIBRINOGEN; HUMANS; INFLAMMATION; THROMBOPHILIA; VASCULITIS;

EID: 84865807474     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-08-0558     Document Type: Article

References (13)

1. Lutgens E, Binder CJ. Immunology of atherosclerosis. Thromb Haemost 2011; 106: 755-756.
2. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011; 473: 317-325.
3. Fish RJ, Neerman-Arbez M. Fibrinogen gene regulation. Thromb Haemost 2012; 108:419-426.
4. Fish RJ, Neerman-Arbez M. A novel regulatory element between the human FGA and FGG genes. Thromb Haemost 2012; 108:427-434.
5. Martin-Ventura JL, Madrigal-Matute J, Martinez-Pinna R, et al., Erythrocytes, leukocytes and platelets as a source of oxidative stress in chronic vascular diseases: Detoxifying mechanisms and potential therapeutic options. Thromb Haemost 2012; 108: 435-442.
6. Matusik P, Guzik B, Weber C, et al. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost 2012; 108: 443-456.
7. Satta J, Laara E, Juvonen T Intraluminal thrombus predicts rupture of an abdominal aortic aneurysm. JVascSurg 1996; 23: 737-739.
8. Yla-Herttuala S, Bentzon JF, Daemen M, et al. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology. Thromb Haemost 2011; 106: 1-19.
9. Schramm A, Matusik P, Osmenda G, et al. Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 2012; 56: 216-231.
10. Flierl U, Schafer A, Fractalkine - a local inflammatory marker aggravating platelet activation at the vulnerable plaque. Thromb Haemost 2012; 108: 457-463.
11. Lucas AD, Bursill C, Guzik TJ, et al. Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemo-taxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 2003; 108:2498-2504.
12. Wojakowski W, Tendera M, Cybulski W, et al. Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxyge-nase-1 on the myocardial reperfusion injury. Thromb Haemost 2012; 108:464-475.
13. Grochot-Przeczek A, Dulak J, Jozkowicz A. Heme oxygenase-1 in neovascularisation: A diabetic perspective. Thromb Haemost 2010; 104: 424-431.